TVRD
Tvardi Therapeutics, Inc.
1.60$
-6.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -38.3% | -28.9% | -53.6% | +157.9% | -43.1% | +76.6% | -100.0% | – | – | – | – | – | |
| – | -57.3% | -10.1% | -99.2% | +1,360.0% | – | – | – | – | – | – | – | – | |
| – | -28.8% | -34.5% | -100.3% | – | -43.1% | +81.8% | -101.8% | – | – | – | – | – | |
| – | +11.6% | -22.6% | -70.3% | -26.6% | +79.4% | -96.3% | +1,720.1% | -37.9% | +52.4% | -10.6% | -18.5% | – | |
| – | – | +895.0% | -90.4% | +28.9% | +156.4% | +115.7% | -33.9% | -25.2% | -10.5% | +2.1% | +25.5% | – | |
| – | +8.6% | -10.7% | -77.0% | -20.9% | +90.3% | -54.1% | +78.0% | -32.7% | +27.8% | -7.1% | -6.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -3.6% | +2.6% | +33.7% | +9.4% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -232.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -232.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -230.6% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.